415 related articles for article (PubMed ID: 16619037)
1. Cited2 modulates TGF-beta-mediated upregulation of MMP9.
Chou YT; Wang H; Chen Y; Danielpour D; Yang YC
Oncogene; 2006 Sep; 25(40):5547-60. PubMed ID: 16619037
[TBL] [Abstract][Full Text] [Related]
2. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
[TBL] [Abstract][Full Text] [Related]
3. Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators.
Ghosh AK; Yuan W; Mori Y; Varga J
Oncogene; 2000 Jul; 19(31):3546-55. PubMed ID: 10918613
[TBL] [Abstract][Full Text] [Related]
4. Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta.
Chen SJ; Yuan W; Lo S; Trojanowska M; Varga J
J Cell Physiol; 2000 Jun; 183(3):381-92. PubMed ID: 10797313
[TBL] [Abstract][Full Text] [Related]
5. The steroid receptor co-activator-1 (SRC-1) potentiates TGF-beta/Smad signaling: role of p300/CBP.
Dennler S; Pendaries V; Tacheau C; Costas MA; Mauviel A; Verrecchia F
Oncogene; 2005 Mar; 24(11):1936-45. PubMed ID: 15688032
[TBL] [Abstract][Full Text] [Related]
6. Post-transcriptional control of Cited2 by transforming growth factor beta. Regulation via Smads and Cited2 coding region.
Chou YT; Yang YC
J Biol Chem; 2006 Jul; 281(27):18451-62. PubMed ID: 16675452
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of TGF-beta responsive genes by Smad-interacting peptide aptamers from FoxH1, Lef1 and CBP.
Cui Q; Lim SK; Zhao B; Hoffmann FM
Oncogene; 2005 Jun; 24(24):3864-74. PubMed ID: 15750622
[TBL] [Abstract][Full Text] [Related]
8. Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3).
Long J; Wang G; Matsuura I; He D; Liu F
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):99-104. PubMed ID: 14691252
[TBL] [Abstract][Full Text] [Related]
9. Functional cooperation between Smad proteins and activator protein-1 regulates transforming growth factor-beta-mediated induction of endothelin-1 expression.
RodrÃguez-Pascual F; Redondo-Horcajo M; Lamas S
Circ Res; 2003 Jun; 92(12):1288-95. PubMed ID: 12764024
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid receptors interfere with the TGF-beta/Smad signaling pathway in a ligand-specific manner.
Pendaries V; Verrecchia F; Michel S; Mauviel A
Oncogene; 2003 Nov; 22(50):8212-20. PubMed ID: 14603262
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C viral proteins interact with Smad3 and differentially regulate TGF-beta/Smad3-mediated transcriptional activation.
Cheng PL; Chang MH; Chao CH; Lee YH
Oncogene; 2004 Oct; 23(47):7821-38. PubMed ID: 15334054
[TBL] [Abstract][Full Text] [Related]
12. Cyclic adenosine 3',5'-monophosphate-elevating agents inhibit transforming growth factor-beta-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism.
Schiller M; Verrecchia F; Mauviel A
Oncogene; 2003 Dec; 22(55):8881-90. PubMed ID: 14654784
[TBL] [Abstract][Full Text] [Related]
13. Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.
Suh N; Roberts AB; Birkey Reffey S; Miyazono K; Itoh S; ten Dijke P; Heiss EH; Place AE; Risingsong R; Williams CR; Honda T; Gribble GW; Sporn MB
Cancer Res; 2003 Mar; 63(6):1371-6. PubMed ID: 12649201
[TBL] [Abstract][Full Text] [Related]
14. Roles for lysine residues of the MH2 domain of Smad3 in transforming growth factor-beta signaling.
Imoto S; Sugiyama K; Sekine Y; Matsuda T
FEBS Lett; 2005 May; 579(13):2853-62. PubMed ID: 15907489
[TBL] [Abstract][Full Text] [Related]
15. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.
Kuang C; Chen Y
Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling.
Seo T; Park J; Choe J
Cancer Res; 2005 Mar; 65(5):1738-47. PubMed ID: 15753369
[TBL] [Abstract][Full Text] [Related]
18. Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-beta signaling.
Sun Y; Lowther W; Kato K; Bianco C; Kenney N; Strizzi L; Raafat D; Hirota M; Khan NI; Bargo S; Jones B; Salomon D; Callahan R
Oncogene; 2005 Aug; 24(34):5365-74. PubMed ID: 16007227
[TBL] [Abstract][Full Text] [Related]
19. Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts.
Ihn H; Yamane K; Asano Y; Jinnin M; Tamaki K
Rheumatology (Oxford); 2006 Feb; 45(2):157-65. PubMed ID: 16319104
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
Yuan W; Varga J
J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]